Netherlands
The Biotechnology company in Netherlands with the highest Sales to Working Capital Ratio 5 year CAGR is Uniqure NV (NASDAQ: QURE) at 8.93%.
The Biotechnology company in Netherlands with the lowest Sales to Working Capital Ratio 5 year CAGR is Uniqure NV (NASDAQ: QURE) at 8.93%.
The top 10 Biotechnology companies in Netherlands by Sales to Working Capital Ratio 5 year CAGR are and Uniqure NV.
The bottom 10 Biotechnology companies in Netherlands by Sales to Working Capital Ratio 5 year CAGR are and Uniqure NV.